BioPharma Credit PLC Director/PDMR Shareholding (1632R)

TIDMBPCR

RNS Number : 1632R

BioPharma Credit PLC

12 June 2018

BIOPHARMA CREDIT PLC

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 
 1.   Details of person discharging managerial 
       responsibilities/person closely associated 
       with them 
---  ------------------------------------------------------------- 
 a)   Name                   Anita Hyman 
---  ---------------------  -------------------------------------- 
 2.   Reason for the notification 
---  ------------------------------------------------------------- 
 a)   Position               Person Closely Associated with 
       / status               Harry Hyman (Director of BioPharma 
                              Credit PLC) 
---  ---------------------  -------------------------------------- 
 b)   Initial notification   Initial notification 
       / amendment 
---  ---------------------  -------------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, 
       auctioneer or auction monitor 
---  ------------------------------------------------------------- 
 a)   Name                   BioPharma Credit PLC 
---  ---------------------  -------------------------------------- 
 b)   LEI                    213800AV55PYXAS7SY24 
---  ---------------------  -------------------------------------- 
 4.   Details of the transaction(s): section 
       to be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
---  ------------------------------------------------------------- 
 a)   Description              Ordinary Shares of $0.01 each 
       of the financial         GB00BDGKMY29 
       instrument 
       Identification 
       Code 
---  -----------------------  ------------------------------------ 
 b)   Nature of                Purchase of Shares (acquired 
       the transaction          as part of dividend reinvestment) 
---  -----------------------  ------------------------------------ 
 c)   Price(s)                        Price(s)     Volume(s) 
       and volume(s)             ---  -----------  ---------- 
                                  1.   GBP0.80776   17 
                                 ---  -----------  ---------- 
                                  2.   GBP0.7549    18 
                                 ---  -----------  ---------- 
                                  3.   GBP0.7268    40 
                                 ---  -----------  ---------- 
---  -----------------------  ------------------------------------ 
 d)   Aggregated               N/A 
       information 
       - Aggregated 
       volume 
       - Price 
---  -----------------------  ------------------------------------ 
 e)   Date of the              1. 20.11.17 
       transaction 
                                2. 18.02.18 
                                3. 16.04.18 
---  -----------------------  ------------------------------------ 
 f)   Place of                 London Stock Exchange (XLON) 
       the transaction 
---  -----------------------  ------------------------------------ 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHBSGDLGSBBGID

(END) Dow Jones Newswires

June 12, 2018 11:00 ET (15:00 GMT)